Femara 2.5 mg Tablets clinical trials

Impact of EXercise on quality of life of early breast cancer patients on treatment with adjuvant Aromatase Inhibitors with or without CDK4/6 inhibitors. "The EX-AI study"

This study looks at how exercise affects the quality of life for women with early breast cancer. These women are taking hormone treatments, sometimes with another medicine called a CDK4/6 inhibitor. The study wants to see if exercise helps with symptoms and overall well-being.